Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-12-01T04:30:36.560Z Has data issue: false hasContentIssue false

Tuberculosis in Long-Term–Care Facilities

Published online by Cambridge University Press:  02 January 2015

Shobita Rajagopalan*
Affiliation:
Department of Internal Medicine, Charles R. Drew University of Medicineand Science, King-Drew Medical Center, Los Angeles, California Division of Infectious Diseases, Charles R. Drew University of Medicineand Science, King-Drew Medical Center, Los Angeles, California
Thomas T. Yoshikawa
Affiliation:
Department of Internal Medicine, Charles R. Drew University of Medicineand Science, King-Drew Medical Center, Los Angeles, California
*
Department of Internal Medicine, Division of Infectious Disease, Mailpoint 11, Room 4015, King-Drew Medical Center, 12021 South Wilmington Ave, Los Angeles, CA 90059

Abstract

The geriatric population represents the largest reservoir of Mycobacterium tuberculosis infection in developed nations, including the United States. Tuberculosis (TB) case rates in the United States are highest for this age group compared with other age categories. The subtle clinical manifestations of TB in the elderly often can pose potential diagnostic dilemmas and therapeutic challenges, resulting in increased morbidity and mortality in this age group; this treatable infection unfortunately often is detected only at autopsy. Compared with their community-dwelling counterparts, the institutionalized elderly are at a greater risk both for reactivation of latent TB and for the acquisition of new TB infection. Prevention and control of TB in facilities providing long-term care to the elderly thus cannot be overemphasized.

Type
Topics in Long-Term Care
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Stead, W, Lofgren, J, Warren, E, Thomas, C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985;312:14831487.Google Scholar
2. Centers for Disease Control. Prevention and control of tuberculosis in facilities providing long-term care to the elderly. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990;39(RR-10):720.Google Scholar
3. Yoshikawa, TT, Norman, DC. Infection control in long-term care. Clin Geriatr Med 1995;11:467480.Google Scholar
4. Brewer, TF, Heymann, SJ, Stevens, JP. New approaches to preventing and eliminating tuberculosis in the United States. Infect Med 2000;17:4548.Google Scholar
5. World Health Organization. The World Health Report. Making a Difference. Geneva, Switzerland: WHO; 1999;3:310320.Google Scholar
6. Centers for Disease Control. Tuberculosis elimination revisited: obstacles, opportunities, and renewed commitment. Advisory Council for the Elimination of Tuberculosis. MMWR 1999;48(RR-9):114.Google Scholar
7. Zuber, PLF, McKenna, MT, Binkin, NJ, Onorato, IM, Castro, KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278:304307.Google Scholar
8. Yoshikawa, TT. Tuberculosis in aging adults. J Am Geriatr Soc 1992;40:178187.Google Scholar
9. Bloom, BR. Tuberculosis pathogenesis, protection and control: immune mechanisms of protection. Washington, DC: American Society for Microbiology Press; 1994:389415.CrossRefGoogle ScholarPubMed
10. Sahn, SA, Neff, TA. Miliary tuberculosis. Am J Med 1974;56:495505.Google Scholar
11. Nagami, P, Yoshikawa, TT. Tuberculosis in the geriatric patient. J Am Geriatr Soc 1983;31:356363.Google Scholar
12. Molavi, A, LeFrock, JL. Tuberculous meningitis. Med Clin North Am 1985;69:315331.Google ScholarPubMed
13. Tuli, SM. Results of treatment of spinal tuberculosis by “middle path” regime. J Bone and Joint Surg British Volume 1975;57:1323.CrossRefGoogle ScholarPubMed
14. Paus, B. The changed pattern of bone and joint tuberculosis in Norway. Acta Orthop Scand 1977;48:277279.CrossRefGoogle ScholarPubMed
15. Evanchick, CC, Davis, DE, Harrington, TM. Tuberculosis of peripheral joints: an often missed diagnosis. J Rheum 1986;13:187189.Google ScholarPubMed
16. Quinn, W. Genitourinary tuberculosis: a study of 1117 cases over a period of 34 years. Br J Urol 1984;56:449455.Google Scholar
17. Alvarez, S, McCabe, W. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine 1984;63:2555.Google Scholar
18. Lai, KK, Stottmeier, KD, Sherman, IH, McCabe, WR. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA 1984;251:12861288.Google Scholar
19. Centers for Disease Control. Screening for tuberculosis and tuberculous infection in high-risk populations, and the use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990;39(RR-8):112.Google Scholar
20. American Thoracic Society. Treatment and prevention of tuberculosis in adults and children. Am J Respir Crit Care Med 1994;149:13591374.Google Scholar
21. Chaparas, SD. Immunity in tuberculosis. Bull WHO 1982;60:447462.Google Scholar
22. Nash, DR, Douglass, JE. Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses. Chest 1980;77:3235.Google Scholar
23. Thompson, NJ, Glassroth, JL, Snider, DE Jr Farer, LS. The booster phenomenon in serial tuberculin screening. Am Rev Resp Dis 1979;119:587597.Google Scholar
24. Morris, CDW. The radiography, haematology and bronchoscopy of pulmonary tuberculosis in the aged. Quart J Med 1989;71:529536.Google Scholar
25. Centers for Disease Control and Prevention. Nucleic acid amplification tests for tuberculosis. MMWR 1996;45:950952.Google Scholar